$328.95
-0.98-0.3%
Last update: Oct 23, 4:00 PM
Labcorp Holdings Inc (LH) Stock Price, Quote, News & History
LHNYSE
Labcorp will purchase Myriad Genetics' prenatal testing business for $210 million in cash, projecting $160 million in year-one revenue.
You can purchase shares of Labcorp Holdings (NYSE:LH) through any online brokerage.
Other companies in Labcorp Holdings’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Quest Diagnostics Inc (NYSE:DGX), Guardant Health Inc (NASDAQ:GH) and Fresenius Medical Care AG (NYSE:FMS).
Labcorp Holdings has a consensus price target of $301.76.
The stock price for Labcorp Holdings (NYSE: LH) is $328.95 last updated October 23, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Labcorp Holdings.
Labcorp Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Labcorp Holdings.
Labcorp Holdings is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests,...
